Mergers and Acquisitions - Suochen Technology's wholly-owned subsidiary plans to acquire 48% equity of its controlling subsidiary for 86.4 million yuan, resulting in 100% ownership of the subsidiary after the transaction [1] - Zhiyang Innovation is planning to acquire control of Lingming Photon Technology through issuing ordinary shares, convertible bonds, and cash payments, which is expected to constitute a major asset restructuring and related party transaction [2] - Kailong High-Tech intends to purchase 70% equity of Shenzhen Jinwangda Electromechanical Co., Ltd. through issuing shares and cash payments, while also planning to raise matching funds not exceeding 100% of the transaction price [3] Performance Disclosure - Yabo Xuan reported a net profit of 64.75 million yuan for 2025, representing a year-on-year increase of 34.16%, with total revenue of 598 million yuan, up 58.73% year-on-year [4] - Zhongyuan Media announced a net profit of 1.349 billion yuan for 2025, showing a year-on-year growth of 30.99%, despite a total revenue decline of 5.13% to 9.351 billion yuan [5] Shareholding Changes - Dahao Technology announced that four shareholders plan to reduce their holdings by up to 1% each, totaling a maximum of 11.1665 million shares [6] - Changchun Yidong disclosed that FAW Equity Company intends to reduce its holdings by up to 3%, equating to a maximum of 424,550 shares [7] - Jiangyan Group's shareholder plans to reduce its holdings by up to 3%, amounting to a maximum of 1.92833 million shares [8] - Shangluo Electronics' controlling shareholder intends to reduce its holdings by up to 3%, which is approximately 2.05015 million shares [9]

证券日报网讯2月3日，商络电子（300975）在互动平台回答投资者提问时表示，公司与核心原厂保持长 期稳定合作，目前相关内存条供货渠道稳定。公司将紧跟市场供需变化，做好上下游需求匹配与衔接， 多举措保障供应链稳定与成本可控。 ...

格隆汇2月3日丨商络电子(300975.SZ)公布，控股股东、实际控制人、董事长、总经理沙宏志先生持有 公司股份247,559,720股，占剔除回购专用账户股份后公司总股本的36.23%，拟在本公告披露日起15个 交易日后的3个月内（即2026年3月5日至2026年6月4日，窗口期除外）通过集中竞价交易和大宗交易方 式减持其持有的公司股份合计不超过20,501,520股（占剔除回购专用账户股份后公司总股本的3%）。 ...

格隆汇2月3日丨商络电子(300975.SZ)公布，控股股东、实际控制人、董事长、总经理沙宏志先生持有 公司股份247,559,720股，占剔除回购专用账户股份后公司总股本的36.23%，拟在本公告披露日起15个 交易日后的3个月内（即2026年3月5日至2026年6月4日，窗口期除外）通过集中竞价交易和大宗交易方 式减持其持有的公司股份合计不超过20,501,520股（占剔除回购专用账户股份后公司总股本的3%）。 ...

证券日报网讯2月3日，商络电子（300975）在互动平台回答投资者提问时表示，公司于2025年12月下旬 完成对立功科技的股权交割，因此公司2025年业绩预告未包含立功科技经营数据，公司2026年度的财务 报表将包含立功科技对应期间的经营数据。 ...

以下是第一财经对一些重要公告的汇总，供投资者参考。 【品大事】 黄山旅游：拟投资约5.3亿元建设黄山滨江东路12号酒店项目 黄山旅游公告，公司于2026年2月3日召开第九届董事会第十九次会议，审议通过了《关于投资建设黄山滨江东路12号酒店项目的议案》，同意公司投资建设 黄山滨江东路12号酒店项目，预计投资金额约为5.3亿元，资金来源为公司自筹资金。该项目位于黄山市中心政务区及商务区核心，总建筑面积79178.15平方 米，目前建筑主体已完成。公司将对既有建筑实施全面改造与品质升级，打造高端酒店。项目建设周期预计为24个月，静态投资回收期为16.14年。 杭电股份：公司股票价格短期涨幅较大 存在交易风险 杭电股份公告称，公司股票价格短期涨幅较大，2026年1月30日至2月3日，公司股票已连续3个交易日以涨停价收盘，公司股票价格涨幅累计达32.97%，显 著高于同行业上市公司。公司最新滚动市盈率为负，市盈率绝对值远高于同行业。公司预计2025年年度实现归属于上市公司股东的净利润-30,000万元左 右，存在经营业绩下降风险。公司特别提醒投资者注意二级市场交易风险，理性决策，审慎投资。 旭光电子：拟定增募资不超过1 ...

Group 1 - Fulin Precision's subsidiary Jiangxi Shenghua invested 270 million yuan to establish a joint venture for a 500,000-ton ferrous oxalate project, with a total investment of 1.5 billion yuan expected to be completed by September 30, 2026 [1] - Xuguang Electronics plans to raise up to 1 billion yuan through a private placement to fund high-voltage vacuum arc extinguishing chamber expansion and other projects [2] - Minexplosion Optoelectronics intends to acquire 100% equity of Xiazhi Precision, with the transaction subject to shareholder and regulatory approvals [3] Group 2 - Shangluo Electronics' controlling shareholder plans to reduce his stake by up to 3% due to personal financial needs [4] - Babi Food reported a 1.3% decline in net profit for 2025, despite an 11.22% increase in revenue [5] - Pengding Holdings' subsidiary acquired industrial land in Huai'an for 66.14 million yuan [6] Group 3 - Zhuoyue New Energy's net profit for 2025 increased by 14.16%, despite a 17.43% decline in revenue [7] - Zhongyuan Media's net profit grew by 30.99% in 2025, with revenue decreasing by 5.13% [8] - Huangshan Tourism plans to invest approximately 530 million yuan in a hotel project with a 24-month construction period [9] Group 4 - *ST Jinling's restructuring plan was approved by the court, which may improve the company's financial situation [11] - Jichuan Pharmaceutical's subsidiary paid 80 million yuan for exclusive commercialization rights of a drug [12] - Pilin Bio's subsidiary received a notice for the acceptance of a drug supplement application [13] Group 5 - Nepe Mining terminated its investment in Swiss Veritas Resources AG due to changes in conditions [14] - Jinhui Wine announced a cash dividend of 0.20 yuan per share for the first three quarters of 2025 [15] - Hualan Biological's clinical trial for a new drug received approval for an additional indication [16] Group 6 - Industrial Fulian reported a total of 247 million yuan spent on share buybacks as of January 31, 2026 [17] - Yitong Century was pre-selected for a 107 million yuan project with China Tower [18] - Wanfeng Co. noted uncertainty in future price changes for disperse dyes [19] Group 7 - Bibet's clinical trial application for a new drug was approved by the National Medical Products Administration [21] - Chengbang Co. signed new project contracts worth 40.03 million yuan in Q4 2025 [22] - *ST Hengji received a court ruling for a performance compensation of 175 million yuan [23] Group 8 - Jihua Group is planning a change in control, leading to continued stock suspension [24] - Ningbo Port expects a container throughput of 5.03 million TEUs in January 2026, a 9.5% increase [25] - Hengli Petrochemical's actual controller increased his stake by 3.3 million shares [26] Group 9 - Hongfuhan signed a sales contract worth 480 million yuan with Guangdong Quanxiang [27] - All New Good's shareholder lifted a judicial freeze on 4.36% of the company's shares [28] - Changchun High-tech's subsidiary's clinical trial application for a new drug was accepted [29] Group 10 - Xingqi Eye Medicine's clinical trial for a new drug entered the first/second phase [31] - Hanma Technology reported a 140.04% increase in new energy heavy truck production in January 2026 [32] - Hengfeng Paper plans to invest 349 million yuan in a new green printing project [33] Group 11 - Zhifei Biological's mRNA vaccine for shingles received clinical trial approval [34] - Yutong Bus reported a 15.35% decrease in production in January 2026 [35] - StarNet Ruijie plans to sign a lease contract with an affiliate for a total rent of up to 110 million yuan [36] Group 12 - Hacheng Bonda's director completed a 0.97% share reduction [37] - Hendi Pharmaceutical's application for a new drug was approved [38] - Xinhua Medical's subsidiary received a medical device registration certificate [40] Group 13 - Yaokang Bio reported a 31.49% increase in net profit for 2025 [41] - Gaotie Electric reported a 14.02% increase in net profit for 2025 [42]

智通财经APP讯，商络电子(300975.SZ)公告，公司控股股东、实际控制人、董事长、总经理沙宏志先生 拟在2026年3月5日至2026年6月4日通过集中竞价交易和大宗交易方式减持其持有的公司股份合计不超过 2050.15万股(占剔除回购专用账户股份后公司总股本的3%)。 ...

智通财经APP讯，商络电子(300975.SZ)公告，公司控股股东、实际控制人、董事长、总经理沙宏志先生 拟在2026年3月5日至2026年6月4日通过集中竞价交易和大宗交易方式减持其持有的公司股份合计不超过 2050.15万股(占剔除回购专用账户股份后公司总股本的3%)。 ...

商络电子公告，控股股东、实际控制人沙宏志持有2.48亿股，占剔除回购专用账户股份后公司总股本 36.23%，拟于2026年3月5日至2026年6月4日期间，通过集中竞价和大宗交易减持不超过2050.15万股， 占剔除回购专用账户股份后公司总股本3%，减持原因为个人资金需求。 （文章来源：第一财经） ...